N-(3-(2-(2-(3-aminopropoxy)ethoxy)ethoxy)propyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide hydrochloride

Catalog No. :
ACPCOY489
CAS No. :
1314885-95-4
Molecular Formula :
C20H39ClN4O5S
Molecular Weight :
483.08

IUPAC Name:N-(3-(2-(2-(3-aminopropoxy)ethoxy)ethoxy)propyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide hydrochloride

N-(3-(2-(2-(3-aminopropoxy)ethoxy)ethoxy)propyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$189.00Login to see priceInquiryInquiry
250mg95%$328.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-(2-(2-(3-aminopropoxy)ethoxy)ethoxy)propyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide hydrochloride
IUPAC NameN-(3-(2-(2-(3-aminopropoxy)ethoxy)ethoxy)propyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide hydrochloride
Molecular FormulaC20H39ClN4O5S
Molecular Weight483.08
SMILESO=C(NCCCOCCOCCOCCCN)CCCC[C@@H]1SC[C@]([C@]1([H])N2)([H])NC2=O.[H]Cl
InChI KeyBPAUFUWFBBGYGE-QMBKNIKNSA-N
SynonymN-[3-[2-[2-(3-Aminopropoxy)ethoxy]ethoxy]propyl]-biotinamide HCl
CAS No.1314885-95-4

Synthetic Route by SureRoute

1. ACPCOY489 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZSOT918 route compound structure diagram
    ACZSOT918194920-62-2 In Stock
  2. Plus
  3. ACBWUK036 route compound structure diagram
    ACBWUK03658-85-5 In Stock
  4. Then
  5. ACPCOY489 route product structure diagram
    ACPCOY4891314885-95-4
Inquiry

2. ACPCOY489 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPCOY489 route product structure diagram
    ACPCOY4891314885-95-4
Inquiry

Comments (0)